• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应用半参数和非参数方法评估病例对照研究中的风险预测模型。

Assessing risk prediction models in case-control studies using semiparametric and nonparametric methods.

机构信息

Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY 10032, USA.

出版信息

Stat Med. 2010 Jun 15;29(13):1391-410. doi: 10.1002/sim.3876.

DOI:10.1002/sim.3876
PMID:20527013
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3045657/
Abstract

The predictiveness curve is a graphical tool that characterizes the population distribution of Risk(Y)=P(D=1|Y), where D denotes a binary outcome such as occurrence of an event within a specified time period and Y denotes predictors. A wider distribution of Risk(Y) indicates better performance of a risk model in the sense that making treatment recommendations is easier for more subjects. Decisions are more straightforward when a subject's risk is deemed to be high or low. Methods have been developed to estimate predictiveness curves from cohort studies. However, early phase studies to evaluate novel risk prediction markers typically employ case-control designs. Here, we present semiparametric and nonparametric methods for evaluating a continuous risk prediction marker that accommodates case-control data. Small sample properties are investigated through simulation studies. The semiparametric methods are substantially more efficient than their nonparametric counterparts under a correctly specified model. We generalize them to settings where multiple prediction markers are involved. Applications to prostate cancer risk prediction markers illustrate methods for comparing the risk prediction capacities of markers and for evaluating the increment in performance gained by adding a marker to a baseline risk model. We propose a modified Hosmer-Lemeshow test for case-control study data to assess calibration of the risk model that is a natural complement to this graphical tool.

摘要

预测曲线是一种图形工具,用于描述风险(Y) = P(D=1|Y)的总体分布,其中 D 表示二元结果,如在指定时间段内发生事件,Y 表示预测因子。风险(Y)的分布越广,风险模型的性能越好,因为对于更多的受试者,制定治疗建议就更容易。当一个人的风险被认为高或低时,决策就更简单了。已经开发了从队列研究中估计预测曲线的方法。然而,评估新型风险预测标志物的早期阶段研究通常采用病例对照设计。在这里,我们提出了用于评估连续风险预测标志物的半参数和非参数方法,该方法适用于病例对照数据。通过模拟研究研究了小样本特性。在正确指定的模型下,半参数方法比非参数方法效率高得多。我们将它们推广到涉及多个预测标志物的情况。前列腺癌风险预测标志物的应用说明了比较标志物风险预测能力的方法,以及评估通过向基线风险模型添加标志物获得的性能提高的方法。我们提出了一种用于病例对照研究数据的修改后的 Hosmer-Lemeshow 检验,以评估风险模型的校准,这是对该图形工具的自然补充。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33fc/3045657/a68044ad7caa/nihms-269007-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33fc/3045657/9fd131edda53/nihms-269007-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33fc/3045657/c5d8c507720a/nihms-269007-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33fc/3045657/a68044ad7caa/nihms-269007-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33fc/3045657/9fd131edda53/nihms-269007-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33fc/3045657/c5d8c507720a/nihms-269007-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33fc/3045657/a68044ad7caa/nihms-269007-f0003.jpg

相似文献

1
Assessing risk prediction models in case-control studies using semiparametric and nonparametric methods.应用半参数和非参数方法评估病例对照研究中的风险预测模型。
Stat Med. 2010 Jun 15;29(13):1391-410. doi: 10.1002/sim.3876.
2
A parametric ROC model-based approach for evaluating the predictiveness of continuous markers in case-control studies.一种基于参数ROC模型的方法,用于评估病例对照研究中连续标志物的预测性。
Biometrics. 2009 Dec;65(4):1133-44. doi: 10.1111/j.1541-0420.2009.01201.x.
3
Semiparametric methods for evaluating risk prediction markers in case-control studies.病例对照研究中评估风险预测标志物的半参数方法。
Biometrika. 2009 Dec;96(4):991-997. doi: 10.1093/biomet/asp040. Epub 2009 Oct 12.
4
Evaluating prognostic accuracy of biomarkers under competing risk.评估竞争风险下生物标志物的预后准确性。
Biometrics. 2012 Jun;68(2):388-96. doi: 10.1111/j.1541-0420.2011.01671.x. Epub 2011 Dec 7.
5
Semiparametric methods for evaluating the covariate-specific predictiveness of continuous markers in matched case-control studies.匹配病例对照研究中评估连续标志物协变量特异性预测性的半参数方法。
J R Stat Soc Ser C Appl Stat. 2010;59(3):437-456. doi: 10.1111/j.1467-9876.2009.00707.x.
6
Semiparametric models of time-dependent predictive values of prognostic biomarkers.预后生物标志物时间依赖性预测值的半参数模型
Biometrics. 2010 Mar;66(1):50-60. doi: 10.1111/j.1541-0420.2009.01246.x. Epub 2009 Apr 13.
7
Evaluating the predictiveness of a continuous marker.评估连续标志物的预测性。
Biometrics. 2007 Dec;63(4):1181-8. doi: 10.1111/j.1541-0420.2007.00814.x. Epub 2007 May 8.
8
The added value of percentage of free to total prostate-specific antigen, PCA3, and a kallikrein panel to the ERSPC risk calculator for prostate cancer in prescreened men.游离前列腺特异性抗原百分比、PCA3和激肽释放酶检测组合对前列腺癌欧洲随机筛查研究(ERSPC)风险计算器在预筛查男性中的附加值。
Eur Urol. 2014 Dec;66(6):1109-15. doi: 10.1016/j.eururo.2014.08.011. Epub 2014 Aug 26.
9
[Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].[氯化乙酰甲胆碱支气管激发试验标准技术规范(2023年)]
Zhonghua Jie He He Hu Xi Za Zhi. 2024 Feb 12;47(2):101-119. doi: 10.3760/cma.j.cn112147-20231019-00247.
10
Multi-cohort modeling strategies for scalable globally accessible prostate cancer risk tools.多队列建模策略用于可扩展的全球可及前列腺癌风险工具。
BMC Med Res Methodol. 2019 Oct 15;19(1):191. doi: 10.1186/s12874-019-0839-0.

引用本文的文献

1
A SEMIPARAMETRIC METHOD FOR RISK PREDICTION USING INTEGRATED ELECTRONIC HEALTH RECORD DATA.一种使用综合电子健康记录数据进行风险预测的半参数方法。
Ann Appl Stat. 2024 Dec;18(4):3318-3337. doi: 10.1214/24-AOAS1938. Epub 2024 Oct 31.
2
Assessing the clinical utility of biomarkers using the intervention probability curve (IPC).使用干预概率曲线(IPC)评估生物标志物的临床效用。
Cancer Biomark. 2023 Oct 28:CBM230054. doi: 10.3233/CBM-230054.
3
A clinical prediction model for predicting the surgical site infection after an open reduction and internal fixation procedure considering the NHSN/SIR risk model: a multicenter case-control study.

本文引用的文献

1
Semiparametric methods for evaluating risk prediction markers in case-control studies.病例对照研究中评估风险预测标志物的半参数方法。
Biometrika. 2009 Dec;96(4):991-997. doi: 10.1093/biomet/asp040. Epub 2009 Oct 12.
2
A parametric ROC model-based approach for evaluating the predictiveness of continuous markers in case-control studies.一种基于参数ROC模型的方法,用于评估病例对照研究中连续标志物的预测性。
Biometrics. 2009 Dec;65(4):1133-44. doi: 10.1111/j.1541-0420.2009.01201.x.
3
Assessing the value of risk predictions by using risk stratification tables.
一项考虑NHSN/SIR风险模型的切开复位内固定术后手术部位感染预测的临床预测模型:一项多中心病例对照研究。
Front Surg. 2023 Sep 19;10:1189220. doi: 10.3389/fsurg.2023.1189220. eCollection 2023.
4
Development and Validation of a Novel Diagnostic Nomogram Model Using Serum Oxidative Stress Markers and AURKA for Prediction of Nasopharyngeal Carcinoma.使用血清氧化应激标志物和极光激酶A(AURKA)预测鼻咽癌的新型诊断列线图模型的开发与验证
Cancer Manag Res. 2023 Sep 27;15:1053-1062. doi: 10.2147/CMAR.S402572. eCollection 2023.
5
Two-phase stratified sampling and analysis for predicting binary outcomes.两阶段分层抽样分析用于预测二项结局。
Biostatistics. 2023 Jul 14;24(3):585-602. doi: 10.1093/biostatistics/kxab044.
6
Integrated Biomarkers for the Management of Indeterminate Pulmonary Nodules.用于处理肺结节不明确情况的综合生物标志物
Am J Respir Crit Care Med. 2021 Dec 1;204(11):1306-1316. doi: 10.1164/rccm.202012-4438OC.
7
A multi-locus predictiveness curve and its summary assessment for genetic risk prediction.多基因预测曲线及其对遗传风险预测的综合评估。
Stat Methods Med Res. 2020 Jan;29(1):44-56. doi: 10.1177/0962280218819202. Epub 2019 Jan 7.
8
Correcting Classifiers for Sample Selection Bias in Two-Phase Case-Control Studies.校正两阶段病例对照研究中样本选择偏倚的分类器
Comput Math Methods Med. 2017;2017:7847531. doi: 10.1155/2017/7847531. Epub 2017 Sep 24.
9
More Accurate Oral Cancer Screening with Fewer Salivary Biomarkers.利用更少的唾液生物标志物进行更准确的口腔癌筛查。
Biomark Cancer. 2017 Oct 17;9:1179299X17732007. doi: 10.1177/1179299X17732007. eCollection 2017.
10
Using the Lorenz Curve to Characterize Risk Predictiveness and Etiologic Heterogeneity.使用洛伦兹曲线来表征风险预测性和病因异质性。
Epidemiology. 2016 Jul;27(4):531-7. doi: 10.1097/EDE.0000000000000499.
使用风险分层表评估风险预测的价值。
Ann Intern Med. 2008 Nov 18;149(10):751-60. doi: 10.7326/0003-4819-149-10-200811180-00009.
4
Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design.用于分类或预测的生物标志物准确性的关键评估:研究设计标准
J Natl Cancer Inst. 2008 Oct 15;100(20):1432-8. doi: 10.1093/jnci/djn326. Epub 2008 Oct 7.
5
Evaluating new cardiovascular risk factors for risk stratification.评估用于风险分层的新型心血管危险因素。
J Clin Hypertens (Greenwich). 2008 Jun;10(6):485-8. doi: 10.1111/j.1751-7176.2008.07814.x.
6
Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve.预后模型与诊断模型的统计学评估:超越ROC曲线
Clin Chem. 2008 Jan;54(1):17-23. doi: 10.1373/clinchem.2007.096529. Epub 2007 Nov 16.
7
How to improve reliability and efficiency of research about molecular markers: roles of phases, guidelines, and study design.如何提高分子标志物研究的可靠性和效率:阶段、指南及研究设计的作用
J Clin Epidemiol. 2007 Dec;60(12):1205-19. doi: 10.1016/j.jclinepi.2007.04.020. Epub 2007 Sep 24.
8
Integrating the predictiveness of a marker with its performance as a classifier.将标志物的预测性与其作为分类器的性能相结合。
Am J Epidemiol. 2008 Feb 1;167(3):362-8. doi: 10.1093/aje/kwm305. Epub 2007 Nov 2.
9
Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.评估新标志物的附加预测能力:从ROC曲线下面积到重新分类及其他。
Stat Med. 2008 Jan 30;27(2):157-72; discussion 207-12. doi: 10.1002/sim.2929.
10
Evaluating the predictiveness of a continuous marker.评估连续标志物的预测性。
Biometrics. 2007 Dec;63(4):1181-8. doi: 10.1111/j.1541-0420.2007.00814.x. Epub 2007 May 8.